what we really need is XXII announcing that they have just signed with a major player after having a news release of the FDA meeting. The price would then go ballistic
Yes we do...interesting if you watch NITE. He undercuts the $1 ask all the tine. Then when volume picks up he asks below the current pps. when it crossed $1 last week we saw a tremendous amount of interest of nearly 2M shares...I think when we cross $1 it opens up buying restrictions for certain institutional players. Just my opinion
We will get the price rise everyone wants when the license agreement comes. Why raise the price now as there are many on board who would like to still buy more at these lower prices? What does a few more weeks of this $.95-$1 hurt? Is anybody really selling between now and later in the summer when the big news arrives?
Market Data 
Markets 
AI
